z-logo
open-access-imgOpen Access
Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
Author(s) -
Kušnierová Pavlína,
Zeman David,
Hradílek Pavel,
Čábal Martin,
Zapletalová Olga
Publication year - 2019
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.22948
Subject(s) - neurofilament , cerebrospinal fluid , pathology , medicine , chemistry , immunohistochemistry
Abstract Background Neurofilaments are the major cytoskeletal components of neurons, and cell injury leads to their release into the surrounding area. The aim of this study was to compare the cerebrospinal fluid (CSF) and serum (S) concentrations of neurofilament light chains (NFLs) and phosphorylated neurofilament heavy chains (pNFHs). Methods Neurofilament concentrations were measured in CSF and S samples from 172 patients using three enzyme‐linked immunosorbent assays. Excel, Stata version 13, MedCal version 17.9.7., and NCSS 2007 software were used for the statistical analysis. Results There was a statistically significant correlation between the concentrations of CSF NFL and CSF pNFH ( r s  = 0.748; n = 89; P  < 0.001), but Passing‐Bablok regression showed systematic deviation between the values obtained using the two assays. This indicates that the assays were not interchangeable. CSF pNFH and S pNFH concentrations showed low correlation. The kappa statistic showed moderate conformity between CSF pNFH and CSF NFL concentrations ( κ  = 0.556). Conclusions The CSF NFL and CSF pNFH assays gave clinically consistent results that reflected the degree of axonal damage, independent of any particular neurological diagnosis. The S pNFH assays had a lower predictive value due to the low correlation coefficient and the kappa index of the CSF pNFH method.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here